Tabalumab

DB11657InvestigationalProtein Based Therapies

Tabalumab has been used in trials studying the treatment of Autoimmune Disease, Rheumatoid Arthritis, Kidney Failure, Chronic, Connective Tissue Disease, and Systemic Lupus Erythematosus, among others.

Mechanism: Pharmacologically active on Tumor necrosis factor ligand superfamily member 13B
Curator reviewed
Code names: Ly2127399

Resolves to

Compound

UNIIPQP8VH3MJWCAS1143503-67-6

Targets

Q9Y275TNFSF13B

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

381Drug interactionsStructured to mechanism, not free text

12Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Tabalumab, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account